Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth - PubMed

Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth

F Bussolino et al. J Cell Biol. 1992 Nov.

Abstract

Hepatocyte Growth Factor (HGF, also known as Scatter Factor) is a powerful mitogen or motility factor in different cells, acting through the tyrosine kinase receptor encoded by the MET protooncogene. Endothelial cells express the MET gene and expose at the cell surface the mature protein (p190MET) made of a 50 kD (alpha) subunit disulfide linked to a 145-kD (beta) subunit. HGF binding to endothelial cells identifies two sites with different affinities. The higher affinity binding site (Kd = 0.35 nM) corresponds to the p190MET receptor. Sub-nanomolar concentrations of HGF, but not of a recombinant inactive precursor, stimulate the receptor kinase activity, cell proliferation and motility. HGF induces repairs of a wound in endothelial cell monolayer. HGF stimulates the scatter of endothelial cells grown on three-dimensional collagen gels, inducing an elongated phenotype. In the rabbit cornea, highly purified HGF promotes neovascularization at sub-nanomolar concentrations. HGF lacks activities related to hemostasis-thrombosis, inflammation and endothelial cells accessory functions. These data show that HGF is an in vivo potent angiogenic factor and in vitro induces endothelial cells to proliferate and migrate.

Similar articles

• The hepatocyte growth factor and its receptor.

  Galimi F, Brizzi MF, Comoglio PM. Galimi F, et al. Stem Cells. 1993 Jul;11 Suppl 2:22-30. doi: 10.1002/stem.5530110805. Stem Cells. 1993. PMID: 8401259 Review.

• Stanniocalcin 1 is an autocrine modulator of endothelial angiogenic responses to hepatocyte growth factor.

  Zlot C, Ingle G, Hongo J, Yang S, Sheng Z, Schwall R, Paoni N, Wang F, Peale FV Jr, Gerritsen ME. Zlot C, et al. J Biol Chem. 2003 Nov 28;278(48):47654-9. doi: 10.1074/jbc.M301353200. Epub 2003 Sep 17. J Biol Chem. 2003. PMID: 14500721

• Hepatocyte growth factor/scatter factor stimulates the Ras-guanine nucleotide exchanger.

  Graziani A, Gramaglia D, dalla Zonca P, Comoglio PM. Graziani A, et al. J Biol Chem. 1993 May 5;268(13):9165-8. J Biol Chem. 1993. PMID: 8387483

• Antagonistic effect of NK4, a novel hepatocyte growth factor variant, on in vitro angiogenesis of human vascular endothelial cells.

  Jiang WG, Hiscox SE, Parr C, Martin TA, Matsumoto K, Nakamura T, Mansel RE. Jiang WG, et al. Clin Cancer Res. 1999 Nov;5(11):3695-703. Clin Cancer Res. 1999. PMID: 10589789

Cited by

• HGF-MET cascade, a key target for inhibiting cancer metastasis: the impact of NK4 discovery on cancer biology and therapeutics.

  Mizuno S, Nakamura T. Mizuno S, et al. Int J Mol Sci. 2013 Jan 7;14(1):888-919. doi: 10.3390/ijms14010888. Int J Mol Sci. 2013. PMID: 23296269 Free PMC article.

• Luteolin exerts a marked antitumor effect in cMet-overexpressing patient-derived tumor xenograft models of gastric cancer.

  Lu J, Li G, He K, Jiang W, Xu C, Li Z, Wang H, Wang W, Wang H, Teng X, Teng L. Lu J, et al. J Transl Med. 2015 Feb 1;13:42. doi: 10.1186/s12967-015-0398-z. J Transl Med. 2015. PMID: 25638174 Free PMC article.

• Human blood outgrowth endothelial cells improve islet survival and function when co-transplanted in a mouse model of diabetes.

  Coppens V, Heremans Y, Leuckx G, Suenens K, Jacobs-Tulleneers-Thevissen D, Verdonck K, Lahoutte T, Luttun A, Heimberg H, De Leu N. Coppens V, et al. Diabetologia. 2013 Feb;56(2):382-90. doi: 10.1007/s00125-012-2754-3. Epub 2012 Oct 23. Diabetologia. 2013. PMID: 23090187

• The MET gene is a common integration target in avian leukosis virus subgroup J-induced chicken hemangiomas.

  Justice J 4th, Malhotra S, Ruano M, Li Y, Zavala G, Lee N, Morgan R, Beemon K. Justice J 4th, et al. J Virol. 2015 May;89(9):4712-9. doi: 10.1128/JVI.03225-14. Epub 2015 Feb 11. J Virol. 2015. PMID: 25673726 Free PMC article.

• The hepatocyte growth factor antagonist NK4 inhibits indoleamine-2,3-dioxygenase expression via the c-Met-phosphatidylinositol 3-kinase-AKT signaling pathway.

  Wang D, Saga Y, Sato N, Nakamura T, Takikawa O, Mizukami H, Matsubara S, Fujiwara H. Wang D, et al. Int J Oncol. 2016 Jun;48(6):2303-9. doi: 10.3892/ijo.2016.3486. Epub 2016 Apr 14. Int J Oncol. 2016. PMID: 27082119 Free PMC article.

References

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • Ovid Technologies, Inc.
  • PubMed Central
  • Silverchair Information Systems

• Other Literature Sources

  • The Lens - Patent Citations Database

• Miscellaneous

  • NCI CPTAC Assay Portal